Figure 2 illustrates the core inflammaging pathways linking CHIP, cytokine activation, and vascular/metabolic dysfunction, while Figure 3 depicts the major mutations and key pathophysiological events driving atherosclerosis and CVD in CHIP carriers. This evidence concerns the gene STUB1 and atherosclerosis.